Double-blind, randomised, placebo-controlled, crossover study investigating R213129 effects on scopolamine-induced CNS impairment in healthy males

  • Liem-Moolenaar, M
  • De Boer, P
  • Zoethout, R WM
  • Franson, K
  • Cohen, A F
  • Van Gerven, J MA

  • a Centre for Human Drug Research, Leiden, The Netherlands b Johnson & Johnson Pharmaceutical Research & Development, Beerse, Belgium

British Journal of Clinical Pharmacology 66(5):p 739, November 2008.
Copyright © 2008 Blackwell Publishing Ltd.
View full text|Download PDF